Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Rivaroxaban

Brand: Xarelto┬«
NICE TA: 261
Indication: Treatment of deep vein thrombosis and prevention of recurrent DVT and pulmonary embolism (NICE TA261)
Disease category: Cardiovascular system
Commissioning responsibility: CCG
PbR excluded: No

Background

Recommendation

LMMG recommendation: Amber0
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

NICE TA261 - Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Amber

Amber

Amber 0

Amber0

Amber0